54915-42-3

Upstream product

• 83-41-0 2,3-dimethylnitrobenzene 
• 1237067-27-4 2-{2-(N,N-dimethylamino)vinyl}-3-methylnitrobenzene 
• 54915-41-2 2-(hydroxymethyl)-3-methyl-1-nitrobenzene 

Downstream Products

• 872323-59-6 diethyl (acetylamino)(2-methyl-6-nitrobenzyl)malonate 
• 50608-50-9 N-(2-amino-6-methyl benzyl)-glycine ethyl ester 
• 70018-29-0 2-(2-Amino-6-methyl-benzylamino)-3-hydroxy-propionic acid ethyl ester 
• 70018-30-3 (2-Amino-6-methyl-benzylamino)-phenyl-acetic acid ethyl ester 
• 85061-63-8 1-(2-Methyl-6-nitro-benzyl)-imidazolidine-2,4-dione 
• 85061-67-2 5-Ethoxy-1-(2-methyl-6-nitro-benzyl)-imidazolidine-2,4-dione 
• 70018-44-9 D-1,5-dihydro-3-phenyl-6-methyl-imidazo[2,1-b]quinazolin-2(3H)-one hydrochloride 
• 70018-28-9 N-(2-amino-6-methylbenzyl)-D-alanine ethyl ester 
• 70018-27-8 N-(2-amino-6-methylbenzyl)-L-alanine ethyl ester 
• 85061-74-1 (R)-1-(2-Amino-6-methyl-benzyl)-5-methyl-imidazolidine-2,4-dione 
• 85062-24-4 (S)-1-(2-Amino-6-methyl-benzyl)-5-methyl-imidazolidine-2,4-dione 

Relevant academic research and scientific papers

METHOD FOR PRODUCING NITRO COMPOUND

A compound represented by formula (1): can be produced by: a step wherein a compound represented by formula (2): is reacted with a compound represented by formula (3): thereby obtaining a compound represented by formula (4): a step wherein a compound repr

METHOD FOR PRODUCING 2-(HALOGENOMETHYL)-3-METHYLNITROBENZENE

Position-1 halogen can be selectively reduced by reacting a compound represented by formula (3): [wherein X represents a chlorine atom, a bromine atom, or an iodine atom] with halogen in the presence of a heterogeneous transition metal catalyst to produce 2-(halogenomethyl)-1-methyl-3-nitrobenzene represented by formula (1): [wherein the symbol is as defined above].

Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones

Optionally substituted 1,2,3,5-tetrahydroimidazol[2,1-b]-quinazolin-2-ones and 6-[H]-1,2,3,4-tetrahydropyrimidol[2,1-b]quinazolin-2-ones or the pharmaceutically acceptable salts thereof are compounds useful as blood platelet anti-aggregative and/or antihypertensive and/or bronchodilator agents in mammals, including humans.

Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones

Optionally substituted 1,2,3,5-tetrahydroimidazo[2,1-b]-quinazolin-2-ones and 6-[H]-1,2,3,4-tetrahydropyrimido[2,1-b]-quinazolin-2-ones or the pharmaceutically acceptable salts thereof are compounds useful as blood platelet anti-aggregative and/or antihypertensive and/or bronchodilator agents in mammals, including humans.